DE3767730D1 - 2-substituierte chinolindicarbonsaeure. - Google Patents

2-substituierte chinolindicarbonsaeure.

Info

Publication number
DE3767730D1
DE3767730D1 DE8787301256T DE3767730T DE3767730D1 DE 3767730 D1 DE3767730 D1 DE 3767730D1 DE 8787301256 T DE8787301256 T DE 8787301256T DE 3767730 T DE3767730 T DE 3767730T DE 3767730 D1 DE3767730 D1 DE 3767730D1
Authority
DE
Germany
Prior art keywords
substd
opt
alkyl
benzyl
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8787301256T
Other languages
English (en)
Inventor
Robert N Young
Robert Zamboni
Serge Leger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Frosst Canada and Co
Original Assignee
Merck Frosst Canada and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Frosst Canada and Co filed Critical Merck Frosst Canada and Co
Application granted granted Critical
Publication of DE3767730D1 publication Critical patent/DE3767730D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
DE8787301256T 1986-02-14 1987-02-13 2-substituierte chinolindicarbonsaeure. Expired - Lifetime DE3767730D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA501932 1986-02-14

Publications (1)

Publication Number Publication Date
DE3767730D1 true DE3767730D1 (de) 1991-03-07

Family

ID=4132478

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787301256T Expired - Lifetime DE3767730D1 (de) 1986-02-14 1987-02-13 2-substituierte chinolindicarbonsaeure.

Country Status (14)

Country Link
EP (1) EP0233763B1 (de)
JP (1) JPH0686432B2 (de)
KR (1) KR870007920A (de)
AT (1) ATE60584T1 (de)
AU (1) AU595286B2 (de)
DE (1) DE3767730D1 (de)
DK (1) DK168534B1 (de)
ES (1) ES2031498T3 (de)
GR (1) GR3001474T3 (de)
IE (1) IE59889B1 (de)
IL (1) IL81569A (de)
NZ (1) NZ219249A (de)
PT (1) PT84287B (de)
ZA (1) ZA871064B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0271287A3 (de) * 1986-12-11 1990-06-13 Merck Frosst Canada Inc. Chinolindicarbonsäuren und ihre Amide
US4920130A (en) * 1987-11-02 1990-04-24 Rorer Pharamceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
US4920132A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
US4920131A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
US5204358A (en) * 1987-11-25 1993-04-20 Merck Frosst Canada, Inc. Hetaryl styryl quinolines as leukotriene inhibitors
CA1322004C (en) * 1987-11-25 1993-09-07 Merck Frosst Canada Incorporated Pyridyl styrene dialkanoic acids
IL88433A0 (en) * 1987-11-25 1989-06-30 Merck Frosst Canada Inc Diarylstyrylquinoline diacids and pharmaceutical compositions containing them
US5104882A (en) * 1987-11-25 1992-04-14 Merck Frosst Canada, Inc. Diarylstrylquinoline diacids and pharmaceutical compositions thereof
AU617386B2 (en) * 1987-12-01 1991-11-28 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Substituted quinolines
GB8728051D0 (en) * 1987-12-01 1988-01-06 Leo Pharm Prod Ltd Chemical compounds
US4883878A (en) * 1988-02-08 1989-11-28 Merck & Co. Inc. Process for unsymmetrical dithioacetals and dithioketals
EP0349062A1 (de) * 1988-06-27 1990-01-03 Merck Frosst Canada Inc. Chinolinetheralkansäuren
US5070022A (en) * 1988-12-22 1991-12-03 Merck & Co., Inc. Enzymic process for preparing leukotriene antagonists
NZ233752A (en) * 1989-05-24 1993-05-26 Merck Frosst Canada Inc Substituted quinoline derivatives, preparation and pharmaceutical compositions thereof
US4996214A (en) * 1990-06-28 1991-02-26 Smithkline Beecham Corporation Quinolinyl substituted phenyl/thioalkanoic acid substituted propionic acids and leucotriene antagonist use thereof
DK0480717T3 (da) * 1990-10-12 1999-02-08 Merck Frosst Canada Inc Umættede hydroxyalkylquinolinsyrer som leukotrienantagonister
US5856322A (en) * 1990-10-12 1999-01-05 Merck Frosst Canada, Inc. Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
US5266568A (en) * 1990-10-12 1993-11-30 Merck Frosst Canada, Inc. Hydroxyalkylquinoline ether acids as leukotriene antagonists
IL99683A0 (en) * 1990-10-12 1992-08-18 Merck Frosst Canada Inc Hydroxy alkylquinoline ether acids and pharmaceutical compositions containing them
HUT61980A (en) * 1990-10-12 1993-03-29 Merck Frosst Canada Inc Process for producing saturated hydroxyalkylquinoline acids and pharmaceutical compositions comprising such compounds as active ingredient
US5212180A (en) * 1991-02-21 1993-05-18 Merck Frosst Canada, Inc. Quinoline-containing ketoacids as leukotriene antagonists
IE920499A1 (en) * 1991-02-21 1992-08-26 Merck Frosst Canada Inc Quinoline-containing ketoacids as leukotriene antagonists
US5276044A (en) * 1991-08-14 1994-01-04 Allergan, Inc. Leukotriene receptor antagonist and antihistamine complex pharmaceutical compositions
US5270324A (en) * 1992-04-10 1993-12-14 Merck Frosst Canada, Inc. Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists
CA2136241C (en) * 1992-06-22 2004-01-27 Richard Frenette Fluorinated quinoline indoles as inhibitors of the biosynthesis of leukotrienes
US5964261A (en) * 1996-05-29 1999-10-12 Baxter International Inc. Implantation assembly
AU2230101A (en) * 1999-12-28 2001-07-09 Ube Industries, Ltd. Tricyclic compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE56702B1 (en) * 1982-12-01 1991-11-06 Usv Pharma Corp Antiinflammatory antiallergic compounds
US4625034A (en) * 1985-02-04 1986-11-25 Usv Pharmaceutical Corp. 1,2-Dihydro; 1,2,3,4-tetrahydro; 5,8 dihydro; and 5,6,7,8-tetrahydroquinoline derivatives
EP0206751A3 (de) * 1985-06-18 1988-05-25 Merck Frosst Canada Inc. 2-Substituierte Chinoline, ihre Herstellung und Verwendung

Also Published As

Publication number Publication date
IL81569A0 (en) 1987-09-16
AU6871787A (en) 1987-08-20
PT84287A (en) 1987-03-01
ATE60584T1 (de) 1991-02-15
GR3001474T3 (en) 1992-10-08
EP0233763A2 (de) 1987-08-26
IL81569A (en) 1991-11-21
AU595286B2 (en) 1990-03-29
ZA871064B (en) 1987-10-28
NZ219249A (en) 1990-07-26
KR870007920A (ko) 1987-09-22
JPH0686432B2 (ja) 1994-11-02
JPS62258363A (ja) 1987-11-10
DK72287D0 (da) 1987-02-13
DK72287A (da) 1987-08-15
IE59889B1 (en) 1994-04-20
EP0233763B1 (de) 1991-01-30
ES2031498T3 (es) 1992-12-16
IE870334L (en) 1987-08-14
EP0233763A3 (en) 1988-10-19
DK168534B1 (da) 1994-04-18
PT84287B (pt) 1989-09-14

Similar Documents

Publication Publication Date Title
DE3767730D1 (de) 2-substituierte chinolindicarbonsaeure.
FR2342056A1 (fr) Solution de prise pour ciments ionomeres de verre dentaire
SE430595B (sv) Forfarande och kontaktkammarapparat av ejektortyp for desinficering av strommande kloakvatten
IT1039416B (it) Procedimento per la preparazione di acqua ossigenata
DK207175A (da) Fremgangsmade til fremstilling af cephalosporiner med alfa-acylaminoeddikesyresidekede
IT1014614B (it) Circuito per rivelare la presenza di attivita in banda fonica in una giunzione telefonica
SE392526B (sv) Automatisk anordoing for indikering av sprickor i svetsfogar
FR2276063A1 (fr) Nouveaux copolymeres hydrophiles insolubles dans l'eau
IT8324409A0 (it) Sali di metallo alcalino di acidi procedimento per la preparazione di polietossicarbossilici.
IT1028714B (it) Dispositivo per collegare il corpo esterno di un giunto con una flangia o con un alberto
BE828957A (fr) Joint perfectionne pour turbo-machines
IT1036231B (it) Procedimento ed apparecchio per l introduzione di additivi in una forma di colata
BE828551A (fr) Polyamides solubles dans l'eau
IT1040824B (it) Procedimento pr produrre sali di acidi acetici clorurati
IT942592B (it) Procedimento ed apparecchio per determinare la posizione di una conduttura subacquea durante il suo interramento
IT947509B (it) Procedimento per evitare screpola ture subsuperficiali durante la placcatura e la saldatura
FR2279509A1 (fr) Metal d'apport pour soudures
DK131974C (da) Loddebad til flusmiddelfri lodning med ultralyd
IT954918B (it) Procedimento per preparare acidi carbossilici oppure i sali di metalli alcalini di questi acidi
IT1040561B (it) Procedimento ed apparecchiatura per la depurazione spinta di soluzioni acquose di sali metallici
IT1141406B (it) Sali della cefapirina con aminoacidi
SU536914A1 (ru) Способ сварки внахлестку
IT8148730A0 (it) Composizioni farmaceutiche antibroncospastiche idrosolubili costituite da sali della teofillina con aminoacidi basici
IT1047136B (it) Procedimento per la fabbricazione di dl 6 finel 2 3 5 6 tetraidro immidazo 2 1 8 tiazolo e relativi sali di addizione con acidi
IT973235B (it) Procedimento per la preparazione di acidi monocarbossilici alifati ci superiori

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: MERCK FROSST CANADA & CO, KIRKLAND, QUEBEC, CA

8339 Ceased/non-payment of the annual fee